Mandate

Vinge has advised Papyrus Holding AB

January 11, 2017

Vinge has advised Papyrus Holding AB in connection with its acquisition of Procurator AB from RoosGruppen AB. The Procurator-group is one of the leading suppliers of inter alia protective clothing and personal protective equipment and cleaning and hygiene products in Sweden, Finland, Norway, Denmark and Estonia. The company had revenues of approx. MEUR 120 in 2015. The transaction is subject to relevant approval from the Swedish Competition Authority.

Vinge´s team consisted of partners in charge Christina Kokko (M&A) and Anna Palmérus (competition law) and among others Kristina Ekberg, Oscar Rydén, Johanna Wiberg and Ilze Lukins (M&A), Frida Ställborn (competition law), Sara Strandberg and Lisa Sennerby (employment), Josefine Lanker (financing), Tomas Forsgren (IP), Nicklas Thorgerzon (IT), Kristoffer Larson (real estate), Jasmin Draszka-Ali (CSR) and Andréa Nicolin (agreements).

Related

Vinge advises Egetis Therapeutics in connection with ANI Pharmaceuticals’ public cash offer

On 5 November 2026, ANI Pharmaceuticals, Inc., a U.S. biopharmaceutical company listed on The Nasdaq Global Market, announced a recommended public cash offer to the shareholders of Egetis Therapeutics AB (publ) and to the holder of Egetis’ convertible loan and warrants to tender all shares, the convertible loan and the warrants in Egetis to ANI. The total value of the offer amounts to approximately SEK 5,304 million.
November 10, 2026

Vinge has advised Xspray Pharma in connection with its rights issue

Vinge has advised Xspray Pharma AB (publ) in connection with a rights issue of approximately SEK 90 million before transaction costs, with an over-allotment issue of approximately SEK 72 million.
November 09, 2026

Vinge advises SenzaGen on its acquisition of Alcyomics

SenzaGen AB (publ) has acquired Alcyomics Ltd. The transaction is being financed through a combination of existing cash and a directed issue of convertible bonds.
November 09, 2026